Potential benefits could include reduced need for revision surgeries, lower readmission rates and fewer post-operative infections
More moderate dose escalation, higher protein targets, mandatory resistance training, and potentially shorter treatment courses with emphasis on maintenance dosing may be appropriate
Marys Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea 2 Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Corresponding author: Soo Lim
Fischer, K
Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node
In the Phase 2 trial, the 4 mg group had already lost 12.9% of body weight by week 24, compared to 1.6% for placebo